Showing results (1891-1900 of 2,145) with videos related to

Sort By:
Pageof 215
Stroke|January 24, 2013
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapyW T Longstreth, Richard A Kronmal, John L P Thompson, et al.
Respiratory Medicine|March 2, 2025
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scoresClaus F Vogelmeier, Klaus F Rabe, Surya P Bhatt, et al.
The Lancet. Respiratory Medicine|July 12, 2025
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trialStephanie A Christenson, Nicola A Hanania, Surya P Bhatt, et al.
Circulation|January 21, 2021
Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US CohortBrandon R Allen, Robert H Christenson, Scott A Cohen, et al.
Molecular Cancer Research : MCR|September 15, 2018
Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of ImmunosuppressionThomas J Rogers, Jessica L Christenson, Lisa I Greene, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Dissociable contributions of the amygdala and ventral hippocampus to stress-induced changes in defensive behaviorZachary T Pennington, Alexa R LaBanca, Patlapa Sompolpong, et al.
Chest|February 2, 2025
Dupilumab Improves Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUSSurya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
The Lancet. Respiratory Medicine|December 9, 2024
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trialDave Singh, Christopher E Brightling, Klaus F Rabe, et al.
The American Journal of Cardiology|November 27, 2012
Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC])Rakesh K Mishra, Yongmei Li, Ana C Ricardo, et al.
Breast Cancer Research and Treatment|December 12, 2019
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic propertiesKelly Kyker-Snowman, Robert M Hughes, Christopher L Yankaskas, et al.
Pageof 215